0001161697-24-000164.txt : 20240328
0001161697-24-000164.hdr.sgml : 20240328
20240328164534
ACCESSION NUMBER: 0001161697-24-000164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240327
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elsbernd Brian
CENTRAL INDEX KEY: 0001763511
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24799885
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 03-27-2024
X0508
4
2024-03-27
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001763511
Elsbernd Brian
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Compliance/Legal Officer
0
Common stock, par value $0.001 per share
2024-03-27
4
S
0
25000
16.44
D
124433
D
Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.42 to $16.47 per share.
/s/ Brian Elsbernd
2024-03-28